[AI]■ STORY TIMELINE
ROCHE TAPS RECURSION AI FOR BRAIN DISEASE RESEARCH
Roche is partnering with Recursion, an AI drug discovery company, to identify new targets for brain diseases. The collaboration aims to accelerate drug development and reduce costly failed trials.
Bloomberg Tech+0m
A new generation of AI companies believes it can reduce the number of failed drug trials.